Literature DB >> 20399931

Randomized study of bevacizumab vs ranibizumab for age-related macular degeneration: inappropriate conclusions.

Andrea Messori, Valeria Fadda, Sabrina Trippoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20399931     DOI： 10.1016/j.ajo.2009.12.039

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  2 in total

Review 1.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2014-08-29

2.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.